Haiti vs Namibia: Cause of death, by non-communicable diseases, ages 0-4, female
Haiti
11.7%
in 2021
Namibia
11.4%
in 2021
Haiti rank
141st
Namibia rank
142nd
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Haiti
- Namibia
How they compare
Haiti currently reports 11.7% against 11.4% in Namibia, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Haiti ahead.
Haiti ranks 141st and Namibia ranks 142nd of 185 countries.
Across the 3 decades both report, Haiti averaged higher in 2 and Namibia in 1.
Head to head by decade
| Decade | Haiti | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.8% | 5.4% | 3.5% | Haiti |
| 2010s | 9.1% | 9.8% | 0.7% | Namibia |
| 2020s | 11.9% | 11.5% | 0.4% | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Haiti or Namibia?
- Haiti, at 11.7% against 11.4% in Namibia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Haiti and Namibia?
- 0.3%, with Haiti ahead.
- How many years of comparable data are there for Haiti and Namibia?
- 6 years are reported by both, from 2000 to 2021.
- How do Haiti and Namibia rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Haiti ranks 141st and Namibia ranks 142nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.